FTSE 100, FTSE 250 Jump 1% As Trump Agrees Biden Transition, Covid-19 Vaccine Optimism Supports Rally

3 min read | November 24, 2020 01:38 PM GMT | By Hina Chowdhary

Summary

  • UK stock markets have extended gains on 24 November after Trump confirmed that the Biden transition can begin
  • The optimism around the vaccine development has maintained an elevated mood among the market participants
  • FTSE 100, FTSE 250, FTSE 350 and FTSE All-Share surged more than 1 per cent each following a market wide rally

 

 

UK stock markets surged in the early morning trades on Tuesday, after US President Donald Trump agreed to start the Joe Biden’s transition. A rally was observed in the market today with the headline indices FTSE 100, FTSE 250, FTSE 350 and FTSE All-Share surging nearly 1 per cent. The optimism over the development of coronavirus vaccines and Prime Minister Boris Johnson’s plan for the festive season have seemingly bolstered the investors’ sentiment.

 

Festive season & Biden’s transition

 

On Monday, PM Johnson’s office sent out signals towards the termination of ongoing lockdown next week. However, sources said there will be newer guidelines in the upcoming controlled regime that is going to be implemented across the UK. PM Johnson is likely to reveal the details of the Christmas plan today.

 

In the US, President-elect Joe Biden and Vice President-elect Kamala Harris have been confirmed as the apparent winners in the US presidential elections by GSA Administrator Emily Murphy, the Office of the President-elect said in a notification. President Trump has recommended to begin the “initial protocols”.

 

UK markets extend gains

 

The UK markets have extended the gains following the persisting set of developments on the domestic front, as well as around the globe and the upbeat Asian markets with Japan’s Nikkei 225 settling 2.5 per cent higher. The benchmark FTSE 100 has advanced more than 1 per cent supplementing the positive opening. Interestingly, all the other broader indices of London Stock Exchange have registered a largely similar rise.

 

At the time of writing (around 11:18 am GMT), the FTSE 250 was trading at 197.94 points or 1.01 per cent higher at 19,780.29, FTSE 350 was trading at 3,645.68, up 36.67 points or 1.02 per cent, while FTSE All-Share index was hovering at 36.29 points or 1.01 per cent higher at 3,618.57. During the day so far, the FTSE 100 has oscillated between a range of 6,403.01 and 6,333.72.

 

FTSE 100 (24 November)

FTSE 250 (24 November)

Earlier on Monday, Dow Jones Industrial Average of New York Stock Exchange ended 327.79 points or 1.12 per cent higher to 29,591.27 after touching an intraday peak of 29,667.75, whereas Nasdaq Composite and the broader S&P 500 concluded marginally higher at 11,880.63, up 0.22 per cent and 3,577.59, up 0.56 per cent, respectively.

 

DJIA (23 November)

(Source: Thomson Reuters)

 

Better times ahead?

 

The upcoming weeks can be very crucial for the world markets following the news around Covid-19 vaccines and a new government in the US. Most of the developed countries have already booked millions of doses of the potential coronavirus vaccine from various pharmaceutical companies and authorised drug developers. Initially, most countries have reserved the first doses of the vaccine for their frontline workers and healthcare staff, including doctors and care staff and people working in order to ascertain a regular supply of essential items.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


Sponsored Articles


Investing Ideas

Previous Next